Adhesives Research, Inc., announces that its ARx division broke ground on a new 25,000 square-foot facility to manufacture active pharmaceutical products. The new facility will host an extended manufacturing capacity in addition to a larger laboratory space to support the company's growth. The ARx Division currently develops and supplies six dissolvable film product such as Triaminic and Theraflu Thin Strips, an plans to launch an additional 20 products with the building of the new facility.
"We are excited about breaking ground on a new facility for the production of active pharmaceutical products," said ARx vice president and general manager Beth Vondrak in an Adhesive Research press release. The new facility will increase the AR campus to nearly 240,000 feet.